The Overlooked Key to Safer Essential Medicines in Africa
A new analysis of the World Health Organization and 52 African national Essential Medicines Lists (EMLs) reveals a critical gap in public health strategy. The study finds that, on average, one in every eight essential medicines listed has established, actionable pharmacogenomic guidance, yet these drug-gene interactions are not accounted for in current selection processes. This oversight is particularly significant for anti-infective drugs, which represent over a quarter of the medicines with pharmacogenomic biomarkers on these lists.
Continue reading to unlock the full analysis, deeper implications, and why this study may matter for your field.
Unlock Full Briefing — 50% Off with Coupon: ERWMCWYU
Full version includes the complete summary, study significance, and direct link to the original source.
Stay curious. Stay informed — with Science Briefing.
This is a preview briefing. Upgrade to access the full version.
